|
|
Science Sparks @ ACTREC
|
03rd June 2024 |
Vol. No. 13 ; Issue No.633 |
|
Publications
|
1. Kafle Dahal U, Dhimal M, Budukh A, Khadka K, Poudel S, Baral G, Gyanwali P, Jha AK, Chapagain S (2024). Burden of tobacco-related cancers in urban, semi-urban and rural setting of Nepal: Findings from population-based cancer registries 2019. PLoS One. 19(5):e0300271
2. Nair S, Singhvi H, Joshi K, Shetty R, Joshi P, Ghosh-Lashkar S, Chaturvedi P (2024). Oncological safety and feasibility of posterior marginal mandibulectomy vis-à-vis anterior marginal mandibulectomy in oral cancers. South Asian Journal of Cancer.
3. Biswas C, Shetty PM, Sahu A, Velayutham P, Singh V, Shah K, Moiyadi AV (2024). Factors affecting the extent of resection and neurological outcomes following transopercular resection of insular gliomas. Acta Neurochirurgica. 166(1):244.
4. Garg M, Gandhi K, Gera P, Jadhav S, Mohanty B, Gurjar M, Sandupatla B, Gala R, Chaudhari P, Prasad M, Chinnaswamy G, Gota V (2024). Implications of chronic moderate protein-deficiency malnutrition on doxorubicin pharmacokinetics and cardiotoxicity in early post-weaning stage. Life Sciences.
Book Chapter
1. Mehrotra M, Phadte P, Shenoy P, Chakraborty S, Gupta S. Ray P. (2024). Drug-Resistant Epithelial Ovarian Cancer: Current and Future Perspectives. In: Schatten, H. (eds) Cell and Molecular Biology of Ovarian Cancer. Advances in Experimental Medicine and Biology, Vol .1452. Springer, Cham, Pp. 65-96. (ISBN: 978-3-031-58310-0)
|
|
|
Interesting Reads
|
Morsy MHA, Lilienthal I, Lord M, Merrien M, Wasik AM, Sureda-Gómez M, Amador V, Johansson HJ, Lehtiö J, Garcia-Torre B, Martin-Subero JI, Tsesmetzis N, Tao S, Schinazi RF, Kim B, Sorteberg AL, Wickström M, Sheppard D, Rassidakis GZ, Taylor IA, Christensson B, Campo E, Herold N, Sander B. SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma. Blood. 143(19):1953-1964, 2024
|
|
Video of the Week
|
|
Small but Mighty: How Small Changes Can Drive Cancer Cell Progression |
|
|
|
|
|
|
Do You Know?
In 1943, The first electron linear accelerator designed for radiation therapy was developed.
|
|
|
Cancer News
|
|
TMC’s neurosurgery dept gets iUS machine to perform complex brain tumour surgeries
|
Hindustan Times, 02/06/2024
|
The neurosurgery department of the Tata Memorial Centre (TMC) in Parel has procured an intraoperative Ultrasound (iUS) machine which is crucial for safely and accurately removing intrinsic brain tumours. Combined with navigational aids (like surgical GPS systems), the iUS machine allows neurosurgeons... |
|
Breakthrough in cancer prediction with nano informatics and AI
|
Eurekalert, 29/05/2024
|
A recent study has introduced a novel method combining nano informatics and machine learning to precisely predict cancer cell behaviors, enabling the identification of cell subpopulations with distinct characteristics like drug sensitivity and metastatic potential...
|
|
|
|
|
|
|
Tovorafenib approved for some children with low-grade glioma
|
National Cancer Institute, 28/05/2024
|
Food and Drug Administration (FDA) granted accelerated approval to tovorafenib (Ojemda) for kids aged 6 months or older who have low-grade glioma, a type of brain tumor, with changes in a gene called BRAF. The approval applies to tumors that can’t be...
|
|
|
|
|
|
2019 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|